Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Insurers and payers are setting vastly different healthcare prices

Healthcare insurance companies and payers negotiate rates with providers for services and care delivered to consumers, but not all prices are negotiated the same.

Thumbnail

Volume remains high, but healthcare deal values drop

Healthcare deals were still happening at a quick clip during the third quarter of the year, but the value of deals declined, according to the latest analysis from PwC.

Thumbnail

Not everyone agrees Trump's new drug pricing model will work

Industry groups and healthcare experts disagree on various parts of President Trump's new plan to lower Medicare Part B drug prices, which was announced last week.

Thumbnail

Amazon will sell exclusive line of medical products

In another step into the healthcare arena, Amazon has teamed up with a health brand consultancy company to sell exclusive medical products on the Amazon marketplace, CNBC reported.

Thumbnail

Harvard: Seriously ill people face seriously high medical bills, even when insured

More than 90 percent of seriously ill patients in the U.S. have health insurance coverage, but a substantial amount of this population is not financially protected, according to a recent survey.

Thumbnail

Trump signs new opioid bills, introduces rule to lower drug prices

President Trump announced a new rule that would tackle high drug prices by tying payments to international prices and signed a package of opioid bills into law.

Healthcare spending increased across all US states, populations in 2017

Out-of-pocket healthcare spending in the U.S. increased across all states and demographic groups in 2017, following a three-year upward trend that culminated in a record year-over-year growth rate, according to a report from JPMorgan Chase Institute.

Thumbnail

New, one-dose flu medicine approved by FDA

The FDA approved a new flu medicine that could shorten the time people are sick—and it can be taken in one dose.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup